TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7910819

Group type: EXPERIMENTAL
Intervention: Pirbuterol (400 micrograms)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2467091

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg b.i.d.)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Propranolol (80 mg b.i.d.)
Number of subjects: 444
Study: 29099926

Group type: EXPERIMENTAL
Intervention: Removable functional appliances (Bionator or Activator) followed by full-fixed appliances
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Prepubertal Class II treatment with removable functional appliances
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (untreated Class II malocclusion)
Number of subjects: 46
Study: 27195073

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise for 24 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (sedentary participants)
Number of subjects: 100
Study: 25038853

Group type: EXPERIMENTAL
Intervention: Visual assessment of chest CT in continuous smokers
Number of subjects: 1990

Group type: COMPARATOR
Intervention: Visual assessment of chest CT in former smokers
Number of subjects: 1990

Group type: EXPERIMENTAL
Intervention: Visual assessment of chest CT for interstitial abnormalities
Number of subjects: 1990
Study: 22952172

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Roux-en-Y Gastric Bypass (RYGBP)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: SG
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: RYGBP
Number of subjects: 58
Study: 20940381

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (maintain hematocrit ≥30%)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (maintain hematocrit ≥24%)
Number of subjects: 502
Study: 19549433

Group type: EXPERIMENTAL
Intervention: Somatropin inhalation powder (SIP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Subcutaneously injected rhGH (Hsc)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 26
Study: 16168780

Group type: EXPERIMENTAL
Intervention: Early radiotherapy (54 Gy in fractions of 1.8 Gy)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control (deferred radiotherapy until progression)
Number of subjects: 314
Study: 11879237

Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recycling System (MARS) treatment
Number of subjects: 103
Study: 9880443

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (L‐GG)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 7721639

Group type: EXPERIMENTAL
Intervention: Pretreatment quality control review of radiation therapy fields
Number of subjects: 625

Group type: COMPARATOR
Intervention: No pretreatment quality control review
Number of subjects: 625
Study: 1741738

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (individual or group)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (individual therapy)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (group therapy)
Number of subjects: 19
Study: 6807240

Group type: EXPERIMENTAL
Intervention: Prostacycline (PGI2) infusion at 25 ng/Kg/min before Heparin, then 50 ng/Kg/min during bypass
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prostacycline (PGI2) infusion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 28
Study: 30932252

Group type: EXPERIMENTAL
Intervention: At-home respiratory polygraphy
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Scoring with nasal airflow signal present
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Scoring without nasal airflow signal
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Scoring with RIP flow
Number of subjects: 113
Study: 29121268

Group type: EXPERIMENTAL
Intervention: Polygenic score for schizophrenia (SCZ)
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Cross-trait meta-GWAS
Number of subjects: 2586
Study: 27657546

Group type: EXPERIMENTAL
Intervention: Methylene Blue Injection
Number of subjects: 102

Group type: COMPARATOR
Intervention: Hookwire Insertion
Number of subjects: 102
Study: 23656594

Group type: EXPERIMENTAL
Intervention: Milk with L. paracasei SD1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milk without L. paracasei SD1 (Control)
Number of subjects: 30
Study: 22056151

Group type: EXPERIMENTAL
Intervention: Appetite rating (very good to very poor) on dialysis days
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Appetite rating (very good to very poor) on nondialysis days
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Serum creatinine
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Poor appetite on dialysis days
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Poor appetite on nondialysis days
Number of subjects: 1846
Study: 19172517

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg once daily (group A)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1800 mg daily (group B)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Combined therapy of pitavastatin and EPA (group C)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Healthy controls (normolipidemic patients)
Number of subjects: 191
Study: 17993028

Group type: EXPERIMENTAL
Intervention: Crest Vivid White whitening dentifrice used twice daily
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Crest Vivid White Night used at night and Crest Cavity Protection used in the morning
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control power toothbrush with cavity protection dentifrice
Number of subjects: 52
Study: 16848361

Group type: EXPERIMENTAL
Intervention: Hormonal therapy after radical prostatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hormonal therapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant hormonal therapy (combined with prostatectomy and radiotherapy)
Number of subjects: 0
Study: 14693305

Group type: EXPERIMENTAL
Intervention: Stevioside (500 mg, 3 times daily for 2 years)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 10978399

Group type: EXPERIMENTAL
Intervention: Vitamin B6 (60 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vitamin B12 (500 microg/day)
Number of subjects: 36
Study: 8677658

Group type: EXPERIMENTAL
Intervention: 10% HES 200/0.62
Number of subjects: 12

Group type: COMPARATOR
Intervention: 6% HES 200/0.62
Number of subjects: 12
Study: 1345022

Group type: EXPERIMENTAL
Intervention: Apulein cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocortisone ointment
Number of subjects: 0
Study: 6229920

Group type: EXPERIMENTAL
Intervention: FAC+HD-MPA i.m.
Number of subjects: 76

Group type: COMPARATOR
Intervention: FAC+HD-MPA p.o.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: FAC+HD-MPA i.m. and FAC+HD-MPA p.o.
Number of subjects: 76
Study: 31571296

Group type: EXPERIMENTAL
Intervention: Radiotherapy with oral nutritional supplements
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nutritional support
Number of subjects: 10
Study: 29023221

Group type: EXPERIMENTAL
Intervention: Active phototherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham phototherapy
Number of subjects: 0
Study: 25690268

Group type: EXPERIMENTAL
Intervention: Metformin treatment and diabetes education
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Insulin therapy (at screening)
Number of subjects: 1092
Study: 25247985

Group type: EXPERIMENTAL
Intervention: Air cleaner in filtration mode
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo filtration mode
Number of subjects: 31
Study: 22116471

Group type: EXPERIMENTAL
Intervention: Cognitive treatment, exposure treatment, or their combination with fluvoxamine
Number of subjects: 91

Group type: COMPARATOR
Intervention: No sudden gains
Number of subjects: 91
Study: 20518948

Group type: EXPERIMENTAL
Intervention: ERN/LRPT (1 g) plus statin, advanced to ERN/LRPT (2 g) after 4 weeks
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Doubling the dose of statin
Number of subjects: 1216
Study: 16829217

Group type: EXPERIMENTAL
Intervention: Inhaled tobramycin
Number of subjects: 508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study: 15654576

Group type: EXPERIMENTAL
Intervention: iomeprol 400 mg iodine/mL
Number of subjects: 22

Group type: COMPARATOR
Intervention: iomeprol 300 mg iodine/mL
Number of subjects: 22
Study: 12397697

Group type: EXPERIMENTAL
Intervention: Angiotensin II type 1 receptor antagonist losartan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme (ACE) inhibitor enalapril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcium antagonist amlodipine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 30
Study: 9974196

Group type: EXPERIMENTAL
Intervention: Intervention group (ankle disk for 10‐15 min at all practice sessions for one 10‐month season)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 237
Study: 8640145

Group type: EXPERIMENTAL
Intervention: Catalet C and Catalet D (allergen extracts)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 2301521

Group type: EXPERIMENTAL
Intervention: Weighted vaginal cones
Number of subjects: 69

Group type: COMPARATOR
Intervention: Interferential therapy
Number of subjects: 69
Study: 7015692

Group type: EXPERIMENTAL
Intervention: Combination of vincristine, nitrosomethylurea, and dactinomycin
Number of subjects: 114

Group type: COMPARATOR
Intervention: DTIC (150 mg/m2 iv days 1, 2, 3, 4, 5)
Number of subjects: 114
Study: 31515419

Group type: EXPERIMENTAL
Intervention: Integrated Qigong
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (attention control)
Number of subjects: 126
Study: 28351399

Group type: EXPERIMENTAL
Intervention: Hyperthermic baths (40 °C), 2 baths per week for 4 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham intervention (green light)
Number of subjects: 36
Study: 26101239

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 4260
Study: 24336671

Group type: EXPERIMENTAL
Intervention: Notch3 expression in placentas from patients with early-onset severe preeclampsia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Notch2 expression in placentas from patients with early-onset severe preeclampsia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Notch2 and Delta-like4 (Dll4) mRNA levels in placentas from patients with early-onset severe preeclampsia
Number of subjects: 0
Study: 21247622

Group type: EXPERIMENTAL
Intervention: Synchrovine® (two doses of PGF(2α), 7 d apart)
Number of subjects: 1297

Group type: EXPERIMENTAL
Intervention: Synchrovine® (chilled semen, cervical TAI at 42 h)
Number of subjects: 1297

Group type: EXPERIMENTAL
Intervention: Synchrovine® (chilled semen, cervical TAI at 51 or 57 h)
Number of subjects: 1297

Group type: EXPERIMENTAL
Intervention: Synchrovine® (intrauterine TAI at 51 or 57 h)
Number of subjects: 1297
Study: 19390338

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 14
Study: 17708123

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 15643648

Group type: EXPERIMENTAL
Intervention: Transdiagnostic treatment for anxiety
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 11136140

Group type: EXPERIMENTAL
Intervention: Lower-extremity flexion to extension
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lower-extremity extension to flexion
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Position 1 to Position 3 (same position)
Number of subjects: 38
Study: 9602985

Group type: EXPERIMENTAL
Intervention: Novel potent 5HT3 receptor antagonist
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study: 7798838

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no pentoxifylline)
Number of subjects: 0
Study: 3391736

Group type: EXPERIMENTAL
Intervention: PPA 37.5 mg (immediate release formulation)
Number of subjects: 6
Study: 31294771

Group type: COMPARATOR
Intervention: Ranibizumab, 0.5 mg, every 4 weeks
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Aflibercept, 2 mg, every 4 weeks
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Aflibercept, 0.5 mg, every 4 weeks
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Aflibercept, 2 mg, every 8 weeks after 3 doses at 4-week intervals
Number of subjects: 1561
Study: 28751662

Group type: EXPERIMENTAL
Intervention: L p -Adaptation method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous state of the art methods
Number of subjects: 0
Study: 26427561

Group type: EXPERIMENTAL
Intervention: Supervised multi-modal physical exercise program (including behavior-oriented techniques)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supervised multi-modal physical exercise program (not including behavior-oriented techniques)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not receiving any supervised intervention)
Number of subjects: 0
Study: 22856681

Group type: EXPERIMENTAL
Intervention: Microfilled composite (Esthet.X/Dentsply/De Trey, Prime&Bond NT/Dentsply/De Trey)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nanohybrid composite (TetricEvoCeram/Vivadent, AdheSE/Vivadent)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Compomer (Dyract eXtra/Dentsply/De Trey, Xeno III Dentsply/De Trey)
Number of subjects: 30
Study: 21371323

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Paper-based intervention
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Email invitations
Number of subjects: 250

Group type: COMPARATOR
Intervention: Postal invitations
Number of subjects: 250
Study: 18286346

Group type: EXPERIMENTAL
Intervention: Support group meeting attendance (ASGM)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No support group meeting attendance (NASGM)
Number of subjects: 46
Study: 16864811

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment in hemodialysis patients
Number of subjects: 374
Study: 12581930

Group type: EXPERIMENTAL
Intervention: Walking and stretching/toning activity
Number of subjects: 174
Study: 15210552

Group type: EXPERIMENTAL
Intervention: Meniett device (self-administered 3 times daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo Meniett device (identical but exerted no pressure)
Number of subjects: 62
Study: 9949705

Group type: EXPERIMENTAL
Intervention: Repetition of words heard earlier
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forced quick response or secondary task while reading words
Number of subjects: 0
Study: 8581453

Group type: EXPERIMENTAL
Intervention: Astemizole-pseudoephedrine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Loratadine-pseudoephedrine
Number of subjects: 50
Study: 2128892

Group type: EXPERIMENTAL
Intervention: CANFIT computer aided design (CAD) software
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 48
Study: 333921

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31631570

Group type: EXPERIMENTAL
Intervention: Curative intent treatment
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Palliative intent treatment
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Prognostic Index (PI) variables
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score system
Number of subjects: 469
Study: 27492480

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Liver Cirrhosis (LC)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Both Diabetes Mellitus and Liver Cirrhosis (DM and LC)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4
Study: 25030801

Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 23318025

Group type: EXPERIMENTAL
Intervention: Conners' Adult ADHD Rating Scale-Investigator Rated: Screening Version
Number of subjects: 0
Study: 21050274

Group type: EXPERIMENTAL
Intervention: 0.10 mg/kg YS
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.50 mg/kg YS
Number of subjects: 96
Study: 19065446

Group type: EXPERIMENTAL
Intervention: Heart Failure Clinic (HF) follow-up
Number of subjects: 163

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 163
Study: 17512770

Group type: EXPERIMENTAL
Intervention: Low-dose apomorphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 15496223

Group type: EXPERIMENTAL
Intervention: Donepezil HCl 5 mg daily for 7 days + Risperidone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Donepezil HCl 5 mg daily for 7 days (Control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 9-OH risperidone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both treatment groups (Donepezil + Risperidone and Donepezil only)
Number of subjects: 16
Study: 11468204

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 10
Study: 9736892

Group type: EXPERIMENTAL
Intervention: Physical therapy intervention (twice‐weekly for 18 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control goals (randomly selected)
Number of subjects: 24
Study: 7991113

Group type: EXPERIMENTAL
Intervention: Antisaccade task in advanced parkinsonian patients
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anticholinergics
Number of subjects: 32
Study: 3276492

Group type: EXPERIMENTAL
Intervention: Thymopentin (50 mg, intravenous injections, three times weekly)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Thymopentin
Number of subjects: 119
Study: 30921049

Group type: EXPERIMENTAL
Intervention: J-Pouch (JP)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Side-to-end Anastomosis (SE)
Number of subjects: 167
Study: 28675927

Group type: EXPERIMENTAL
Intervention: Gold nanoparticles (NPs)
Number of subjects: 269
Study: 26166526

Group type: EXPERIMENTAL
Intervention: Filling intervention group (received filling of the permanent teeth free of charge for 3 years)
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: Health education group (received oral health education for 3 years)
Number of subjects: 691

Group type: COMPARATOR
Intervention: Control group (only accepted oral examination for 3 years)
Number of subjects: 691
Study: 23322676

Group type: COMPARATOR
Intervention: Alendronate (4 years)
Number of subjects: 20340

Group type: COMPARATOR
Intervention: Zoledronic acid (3 years)
Number of subjects: 20340

Group type: COMPARATOR
Intervention: Denosumab (3 years)
Number of subjects: 20340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20340
Study: 22069382

Group type: EXPERIMENTAL
Intervention: Low-frequency left temporal rTMS
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of low-frequency right prefrontal followed by low-frequency left temporal rTMS
Number of subjects: 56
Study: 19863301

Group type: EXPERIMENTAL
Intervention: Dried blood spots stored for 1, 5, 10, 15, or 20 years
Number of subjects: 5
Study: 17223245

Group type: EXPERIMENTAL
Intervention: AHA paddles technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AHA hands free technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERC paddles technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERC hands free technique
Number of subjects: 0
Study: 15498362

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of BMSCs
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (saline injection)
Number of subjects: 69
Study: 11571242

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 9598455

Group type: EXPERIMENTAL
Intervention: WR 238605 (doses ranging from 4 to 600 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: WR 238605
Number of subjects: 48
Study: 8184873

Group type: EXPERIMENTAL
Intervention: Single intravenous injection of 25 mg of conjugated oestrogen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Diluent (control)
Number of subjects: 18
Study: 3280829

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 or 50 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide (650 or 1300 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31722725

Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29024892

Group type: EXPERIMENTAL
Intervention: Life Review Therapy (4-week duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treatment (control)
Number of subjects: 50
Study: 26671952

Group type: EXPERIMENTAL
Intervention: Intraoperative catheter irrigation only
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intraoperative catheter irrigation with postoperative intermittent catheter irrigation three times a day for 3 days
Number of subjects: 48
Study: 24201679

Group type: EXPERIMENTAL
Intervention: Weekly supervised pelvic floor muscle training class and daily home exercise for 16 weeks.
Number of subjects: 175

Group type: COMPARATOR
Intervention: No further intervention (control group).
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Relative risk analysis of UI.
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Relative risk analysis for women with major levator ani muscle defects.
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Relative risk analysis for women without major levator ani muscle defects.
Number of subjects: 175
Study: 21519580

Group type: EXPERIMENTAL
Intervention: Group B (Laskin triangular flap)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Group A (envelope flap modified by Thibauld and Parant)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Group C (envelope flap modified by Laskin)
Number of subjects: 45